Elevance Health Inc (ELV)

Pretax margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 7,711,000 7,887,000 8,376,000 8,079,000 7,791,000 8,001,000 7,872,000 8,076,000 7,934,000 7,133,000 5,519,000 6,323,000 6,238,000 6,725,000 7,825,000 6,129,000 5,985,000 5,429,000 5,182,000 5,233,000
Revenue (ttm) US$ in thousands 171,340,000 168,622,000 165,712,000 160,672,000 156,595,000 153,247,000 149,130,000 144,349,000 138,639,000 133,882,000 129,218,000 124,631,000 121,867,000 117,450,000 112,966,000 109,168,000 104,213,000 100,179,000 96,756,000 94,234,000
Pretax margin 4.50% 4.68% 5.05% 5.03% 4.98% 5.22% 5.28% 5.59% 5.72% 5.33% 4.27% 5.07% 5.12% 5.73% 6.93% 5.61% 5.74% 5.42% 5.36% 5.55%

December 31, 2023 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $7,711,000K ÷ $171,340,000K
= 4.50%

To analyze Elevance Health Inc's pretax margin over the past eight quarters, we observe a fluctuating trend. The pretax margin ranged from a low of 4.53% in Q4 2023 to a high of 5.66% in Q1 2022.

Overall, the pretax margin has shown a slight decline in recent quarters, with Q4 2023 marking a decrease compared to the previous three quarters. This decline may indicate increasing costs or lower revenues relative to income before taxes.

However, it is worth noting that even at its lowest point in Q4 2023, the pretax margin remains above 4%, indicating that Elevance Health Inc is still able to generate a reasonable level of profit before accounting for taxes. Further analysis of the underlying factors affecting the company's financial performance would be necessary to determine the reasons behind the fluctuation in pretax margin and to assess its implications for the company's overall financial health.


Peer comparison

Dec 31, 2023